Burning bush

Other Names

Bastard dittanyBurning euonymusBurning treeCelastrus alataCelastrus alatusCelastrus striataCelastrus striatusCorky spindle treeCorky spindletreeDictamnus albusDictamnus fraxinellaDittanyEuonymus alataEuonymus alatusEuonymus alatus var. ellipticusEuonymus alatus var. microphyllusEuonymus alatus var. pilosusEuonymus alatus var. pubescensEuonymus ellipticusEuonymus striataEuonymus striatusEuonymus verrucosus var. tchefouensisEuropean dittanyFalse dittanyFraxinellaFusain ailéGas plantGui Jian YuNishikigiOriental spindle-treeWhite dittanyWinged burning bushWinged euonymusWinged spindle treeWinged spindletreeWinged wahoo

Synopsis

Burning Bush (Euonymus atropurpureus / Euonymus alatus): A Comprehensive Reference

1. Identity and Nomenclature

1.1 The Naming Problem: Two Distinct Plants

The common name "burning bush" is applied to more than one plant in the genus Euonymus, and the two species most consistently associated with medicinal or dietary-supplement use are Euonymus atropurpureus Jacquin (Eastern wahoo or American burning bush) and Euonymus alatus (Thunb.) Siebold (winged euonymus or winged burning bush). There are two species of Euonymus used in medicine — the spindle tree, E. atropurpureus, and the burning bush, E. americanus, to both of which the term "wahoo" has been indiscriminately applied. Modern literature on dietary supplements uses "burning bush" most consistently to refer to E. alatus in Asian traditional medicine and supplement contexts, while the older North American Eclectic tradition centered on E. atropurpureus. Both belong to the family Celastraceae (the bittersweet family).

1.2 Euonymus atropurpureus — Eastern Wahoo / American Burning Bush

This is a species of shrub in the bittersweet family with the common names American wahoo, eastern wahoo, burningbush, and hearts-bursting-with-love; it is native to eastern North America and is primarily found in the Midwestern United States, though its range extends from southern Ontario south to northern Florida and Texas. It grows in low meadows, open slopes, open woodland, stream banks, and prairies in moist soils, especially thickets, valleys, and forest edges; it is a deciduous shrub growing to 8 m (26 ft) tall, with stems up to 10 cm in diameter, gray smooth and lightly fissured bark, and dark purplish-brown, slender, sometimes four-angled or slightly winged twigs.

The name "wahoo" was a Dakota term for the plant, literally meaning "arrow-wood." The Latin species name, meaning "dark purple," refers to the color of the fruit. Other vernacular names recorded in historical sources include bitter-ash, Indian arrowwood, and spindle tree.

1.3 Euonymus alatus — Winged Euonymus / Asian Burning Bush

Historically noted in Chinese and Korean medicine, E. alatus was first recorded in the ancient Chinese text, China Sheng Nong's Herbal Classic. Its twigs and wings were known as "Gui Jian Yu" in China. In Korean traditional medicine it is referred to as "Gui-junwoo." The Euonymus genus, commonly known as the Spindle Tree or Burning Bush, is a diverse group of deciduous or evergreen shrubs and small trees; this genus includes about 140 species, and they are native to East Asia but are widely distributed across North America, Europe, and other regions.

1.4 Medicinal Parts and Common Preparations

The bark of the root is the primary medicinal part; it has a bitter and somewhat unpleasant taste, and water or alcohol extracts its active constituents. Preparations documented historically and in the supplement trade include:

Dried root bark powder — the raw powdered bark, used in capsule and tablet forms.
Tinctures and liquid extracts — alcoholic extractions of the root bark, often prepared by cold maceration in ethanol, water, and vegetable glycerin.
Decoctions and infusions — water-based preparations historically employed in Native American and Eclectic medicine. It was usually employed in the forms of decoction and infusion; as a diuretic, these preparations were generally made in the proportion of an ounce to a pint of water and administered in doses of a wineglass full.
Solid extracts (euonymin concentrations) — dried powdered solid extracts used in 19th-century Eclectic pharmacy.
Standardized plant extracts — in modern Asian research contexts, ethanol, water, and ethyl acetate fractions of E. alatus have been investigated experimentally.

2. Traditional and Historical Use

2.1 Native American Use of E. atropurpureus

The powdered bark was used by Native Americans and pioneers as a purgative. Decoctions of the bark were used to treat various ailments by several Native American tribes. Historically, various Native American tribes utilized different parts of wahoo for medicinal purposes; the bark was employed to make herbal remedies for conditions such as fever, dysentery, and rheumatism.

2.2 19th-Century North American Eclectic Medicine

The American Eclectic tradition of the 19th century was the period during which E. atropurpureus received its most systematic documentation in Western botanical medicine. Wahoo is a North American shrub or small tree whose bark and root bark were once used in traditional and Eclectic herbal medicine; older practitioners described it as a bitter tonic in tiny amounts and a strong cathartic in larger ones, especially for sluggish digestion, constipation, "torpid liver," and fluid retention.

As a tonic, it entered largely into various popular compounds known as bitters, and as such was used in various conditions of the system such as rheumatism, indigestion, and want of appetite, and was extensively used during convalescence from autumnal intermittents. It was frequently exhibited in the form of decoction as a diaphoretic and diuretic in obstruction of the urinary organs, and was an exceedingly popular remedy as a cathartic in a great number of diseases where a remedy of this class was indicated.

Mr. G.W. Carpenter had introduced the bark some twenty years prior as a remedy for dropsy under the name Wahoo, having obtained knowledge of its virtues in the Western States; it was ascertained to be derived from this plant, which must be distinguished from the Elm of the Southern States, which is also called Wahoo.

Eclectic dosage records from King's American Dispensatory describe: a dose of the tincture from 1 to 4 fluid drachms; of the syrup, from 1 to 2 fluid ounces; of the hydro-alcoholic extract, from 5 to 15 grains; of the powder, from 20 to 30 grains; of specific euonymus, 1 to 30 drops. Specific indications included prostration with irritation of the nerve centers, periodical diseases to supplement the action of quinine, and anorexia, indigestion, and constipation due to hepatic torpor.

It was traditionally used as a liver tonic, cholagogue (stimulating bile flow), laxative, and emetic.

2.3 Asian Traditional Use of E. alatus

E. alatus has been used for over 2,000 years in traditional medicine. In the ShenNong BenCaoJing, the earliest medical monograph in China written in the Eastern Han Dynasty (25–220 AD), E. alatus was recorded to have the functions of invigorating blood circulation, dispersing blood stasis to relieve pain, and indications including irregular menstruation, postpartum abdominal pain, coronary heart disease, diabetes, urticaria, and traumatic injury.

E. alatus has been used in Asia for more than 2,000 years, primarily in China, Japan, and Korea, to treat a variety of ailments including rheumatism, wounds, dysentery, pain, sores, gastrointestinal problems, skin problems, and also to kill insects. The cork cambium on the twigs, commonly known as "Gui-junwoo" in Korean traditional medicine, has particularly been used for over 2,000 years to regulate blood circulation, relieve pain, eliminate stagnant blood, and treat dysmenorrhea, tumors, diabetes, and wounds in Asian countries.

The findings from various ethnomedicinal and pharmacological studies of E. alatus highlight its long history and broad use in traditional medicine across different cultures, particularly in Chinese, Korean, and Japanese folk remedies.

3. Key Constituents and Active Compounds

3.1 Overview of Phytochemical Complexity

More than 100 chemical constituents have been isolated and identified from E. alatus, including flavonoids, terpenoids, steroids, lignans, cardenolides, phenolic acids, and alkaloids. The plant includes 129 natural chemicals that have a range of biological effects, including hepatoprotective, antitumor, antioxidant, and antidiabetic properties. Chemicals such as flavonoids, terpenoids, phenylpropanoids, lignans, steroids, and alkaloids have been identified as the major phytochemicals in E. alatus.

3.2 Cardiac Glycosides (Cardenolides)

The most toxicologically and historically significant compounds in both E. atropurpureus and E. alatus are the cardiac glycosides. The best-known constituents associated with Euonymus atropurpureus are cardioactive glycosides, sometimes described in older literature as digitalis-like compounds; earlier pharmacognosy work isolated cardiac glycosides from the plant, and these compounds are the most important reason wahoo is treated with caution today — they can influence heart function, especially if the dose is too high or if the user is vulnerable because of illness, dehydration, or medication interactions.

Euonymin, as obtained from E. atropurpureus by Prof. Meyer and Dr. Romin of Dorpat by an elaborate process, is a crystalline glucoside that corresponds in its physiological action closely with digitalin; it is sparingly soluble in water and ether, and easily soluble in alcohol. Various Euonymus species have been shown to contain cytotoxic cardioglycosides, as well as sesquiterpene pyridine alkaloids and a phytohemaglutinin.

For E. alatus specifically, Kitanaka et al. isolated three cytotoxic cardenolides from the woods of E. alatus and identified them as acovenosigenin A 3-O-α-L-rhamnopyranoside, euonymoside A, and euonymusoside A. A PubMed-listed study from 1957 confirmed specific cardiac glycosides from E. atropurpureus, identifying structures labeled euatroside and euatromonoside.

3.3 Euonymin (the Bitter Resinous Principle)

By analysis of W.T. Wenzel, the bark was found to contain a bitter principle named euonymin, asparagin, resin, fixed oil, wax, starch, albumen, glucose, pectin, and salts. Older herbal writers referred to a bitter resinous principle called euonymin; in historical practice, this was linked to the herb's action as a stomachic, cathartic, and cholagogue — it was thought to stimulate appetite and digestive secretions at low doses, while larger amounts irritated the intestine and pushed the bowels strongly.

3.4 Flavonoids

Flavonoids represent the most extensively researched group of bioactive compounds in E. alatus. These include quercetin and its glycosides, and kaempferol and its glycosides. Other flavonoids documented in phytochemical analyses include apigenin and its glycosides, flavanones and their glycosides, catechin, symplocoside, dehydrodicatechin A, catechin lactone A, a novel 3-hydroxycoumarinflavanol, and various flavonoid glycosides.

Phytochemical study on the corks of Euonymus alatus resulted in the isolation of a novel 3-hydroxycoumarinflavanol, along with ten triterpenoids, ten phenolic derivatives, and two flavonoid glycosides.

3.5 Terpenoids

The triterpenes in E. alatus most commonly belong to the lupane type and oleanane type; other types include hopane, ursane, and friedelane. Major components of E. alatus include sesquiterpenes, sesquiterpene alkaloids, triterpenes, flavonoids, and phenolic compounds.

3.6 Phenolic Acids and Other Compounds

Previous studies have reported several biologically active and structurally interesting constituents from E. alatus in the form of sesquiterpenes including sesquiterpene alkaloids, triterpenes, flavonoids, and phenolic compounds. Documented phenolic acids include chlorogenic acid (5-caffeoylquinic acid) and caffeic acid (3,4-dihydroxycinnamic acid), both of which have been studied as matrix metalloproteinase-9 (MMP-9) inhibitors in vitro. Steroids, including stigmast-4-en-3-one, have also been identified and are under active pharmacological investigation.

3.7 Mannit and Organic Acids

Older chemical analyses identified mannit (mannitol) as a seemingly regular constituent of all Euonymus species, alongside the organic acids malic, citric, and tartaric acid, and the plant-specific "euonic acid," as documented in historical pharmacognosy literature from the 1880s.

4. Mechanisms of Action

4.1 Cholagogue / Liver-Stimulating Actions

The key to wahoo's purported action lies in its potent compounds, including various glycosides and alkaloids; these compounds stimulate the liver and gallbladder, promoting bile flow — bile is essential for digesting fats and eliminating waste products — and this cholagogue action (stimulating bile flow) is one of its primary traditional uses.

4.2 Glycemic and Insulin-Signaling Pathways

Studies in vitro and in vivo have demonstrated the hypoglycemic activity of E. alatus extracts and certain constituents; the hypoglycemic activity may be related to regulation of insulin signaling and insulin sensitivity, involving PPARγ and aldose reductase pathways.

Compounds from E. alatus have shown inhibitory effects on α-glucosidase, an enzyme involved in carbohydrate digestion, and prevention of fat cell differentiation; other studies indicate E. alatus's potential in managing diabetes through various mechanisms, including insulin-stimulated glucose uptake without promoting fat cell differentiation.

Their inhibitory effects against protein tyrosine phosphatase 1B (PTP1B) and α-glucosidase enzyme activity were evaluated; specific compounds were non-competitive inhibitors exhibiting potency with IC50 values ranging from 5.6 ± 0.9 to 18.4 ± 0.3 µM against PTP1B. PTP1B inhibition is a recognized strategy for improving insulin sensitivity.

4.3 Anti-Inflammatory Mechanisms

The anti-inflammatory property of E. alatus is thought to be associated with the inhibition of NO production via suppression of iNOS and COX-2 expression through inhibition of IKKα/β, I-κBα, and NF-κB p65 activation, and downregulation of p38, JNK, and ERK mitogen-activated protein kinase signal pathways in RAW 264.7 macrophages.

Among the constituents of E. alatus, a neolignan called abruslactone A was shown to exhibit anti-inflammatory effects in LPS-stimulated RAW-264.7 macrophages through the inhibition of the expression of iNOS.

4.4 Antioxidant Mechanisms

E. alatus extracts have demonstrated antioxidant effects and the ability to inhibit aromatase, an enzyme crucial for estrogen production and a target for breast tumor treatments; E. alatus has also shown strong antioxidant protection to liver cells against oxidative damage, highlighting its potential as a protective agent against oxidative stress.

4.5 Neuroprotective Mechanisms

Cognitive function deficits in aged mice were significantly mitigated by dietary treatments with E. alatus leaf extract (EA-L3); it upregulated brain-derived neurotrophic factor (BDNF) and subsequently activated the ERK/CREB signaling in the mouse hippocampus; it also showed strong anti-inflammatory effects with decreased NF-κBp65, COX-2, and TNF-α.

4.6 Cathartic / Purgative Mechanism

The cathartic action of the North American species was historically attributed to the bitter resinoid euonymin and, at larger doses, to cardiac glycoside-mediated intestinal irritation. The substance known as euonymine of the Eclectics was found to purge actively without griping.

5. Scientific Evidence by Area of Use

Important context: Extracts of E. alatus have been shown to exert a wide spectrum of pharmacological effects including antidiabetic, anti-tumor, anti-inflammatory, hepatoprotective, antioxidant, and antibacterial effects; however, most of the studies have been conducted without clinical research, and research into the plant's toxicological effects has also been limited. There is insufficient evidence to substantiate the efficacy of burning bush in the treatment of any specific health conditions through clinical trials; traditional medicine may have its own anecdotal reports, but these are not a substitute for rigorous clinical trials and scientific research.

5.1 Antidiabetic and Metabolic Effects

Evidence level: Preclinical only (animal/in vitro); no human clinical trials.

Euonymus alatus is a medicinal plant used in some Asian countries for treating various conditions including cancer, hyperglycemia, and diabetic complications, and reviews have outlined the phytochemistry and bioactivities related to antidiabetic actions.

Studies on Euonymus alatus have shown anti-hyperglycemic activities in mice, reducing body weight, insulin, and lipid levels; E. alatus appeared to modulate gene expression related to fat synthesis in the liver and fat tissue. One study used a 50% ethanol extract of E. alatus in high-fat diet-induced hyperglycemic and hyperlipidemic ICR mice to investigate preventive effects on blood sugar and lipid dysregulation.

A study published in Evidence-Based Complementary and Alternative Medicine (2016, PubMed PMID 27642361) reviewed the antidiabetic evidence and found that: studies in vitro and in vivo had demonstrated hypoglycemic activity of E. alatus extracts and certain constituents; the hypoglycemic activity may be related to regulation of insulin signaling and insulin sensitivity, involving PPARγ and aldose reductase pathways. Quercetin and kaempferol isolated from E. alatus have been shown in cell studies to improve glucose uptake in 3T3-L1 cells without adipogenesis activity. Further studies on E. alatus and its bioactive compounds may help develop new agents for treating diabetes and diabetic complications.

5.2 Diabetic Complications: Retinopathy and Nephropathy

Evidence level: Animal and in vitro studies; no human clinical trials.

A traditional Chinese medicine, E. alatus is widely used in the treatment of diabetes; researchers have found that E. alatus could treat diabetic retinopathy (DR) and that stigmast-4-en-3-one (E6) is the active substance responsible for inhibiting angiogenesis in vitro by E. alatus.

A study published in the Journal of Ethnopharmacology (2021) investigated water extracts of E. alatus in retinal vascular endothelial cells (RF/6A) under high-glucose conditions and in KK-Ay diabetic mice administered WEA or water for 12 weeks, with ocular blood flow assessed by Doppler ultrasound. Conclusions indicated that WEA inhibits the migration and tube formation of RF/6A cells and improves diabetic retinopathy by mediating angiogenesis.

A study showed that E. alatus protected rats from experimental diabetic nephropathy induced by uninephrectomy plus STZ treatment; 12-week administration of E. alatus extract decreased HbA1c and pathological changes (extracellular matrix expansion and glomerulosclerosis) in kidney and improved blood lipid profile and kidney function; the effect was associated with downregulation of TGF-β1 expression. Additionally, E. alatus was shown to inhibit the polyol pathway, which is known to be associated with chronic diabetic complications such as neuropathy, nephropathy, and retinopathy.

5.3 Anti-Inflammatory Effects

Evidence level: In vitro and rodent studies; no human clinical trials.

A 2019 study published in Molecules (PMC6864714) isolated a sterol compound from the twigs of E. alatus and tested it in LPS-stimulated RAW 264.7 macrophages. The anti-inflammatory property was associated with inhibition of NO production via suppression of iNOS and COX-2 expression through inhibition of IKKα/β, I-κBα, and NF-κB p65 activation and downregulation of p38, JNK, and ERK MAPK signaling; the findings provide experimental evidence that this compound could be a candidate for an anti-inflammatory agent.

Separate research has documented lignans from E. alatus leaves and twigs that inhibit nitric oxide production in BV2 microglial cells, and chlorogenic acid and caffeic acid isolated from methanol extracts of E. alatus have been characterized as MMP-9 inhibitors, also in in vitro systems.

5.4 Hepatoprotective Effects

Evidence level: Animal studies; no human clinical trials.

A 2019 study (PMC6357326) in 112 male C57BL/6 mice divided into 14 groups — including CCl4-induced liver fibrosis groups and groups treated with E. alatus ethanol extracts (EAE) or isolated monomers (catechin, dihydroquercetin, kaempferol) — examined protection against liver fibrosis. Research has verified that Euonymus alatus ethanol extracts and three different solvent fractions from ethanol extracts all show anti-inflammation effects; all diseases on which E. alatus ethanol extracts have shown effects, such as diabetes, chronic nephrosis, and rheumatoid arthritis, have some relationship with inflammation.

E. alatus has shown strong antioxidant protection to liver cells against oxidative damage, highlighting its potential as a protective agent against oxidative stress.

5.5 Antitumor Effects

Evidence level: In vitro and limited animal studies; no human clinical trials.

Research has identified cytotoxic cardenolides from E. alatus wood which exhibit strong effects against some cancer cell lines. Previous studies have reported antiproliferative triterpenoids against A549, SK-OV-3, SK-MEL-2, and HCT-15 cell lines from extracts of twigs of E. alatus.

E. alatus extracts have demonstrated the ability to inhibit aromatase, an enzyme crucial for estrogen production and a target for breast tumor treatments. In an in vitro study, aromatase-inhibiting potency of E. alatus was examined in myometrial and leiomyomal cells containing aromatase.

E. alatus has potential for the treatment of many diseases, especially tumors and diabetes; however, many traditional uses of E. alatus have not been validated by current investigations.

5.6 Neurological and Cognitive Effects

Evidence level: Animal studies; no human clinical trials.

A 2024 study (PMC11047375) examined the impact of E. alatus leaf extract (EA-L3) on age-dependent oxidative stress, neuroinflammation, and progressive memory impairments in aged mice. Twenty-four-month-old mice received EA-L3 at 300 mg/kg/day, or the reference drug donepezil at 5 mg/kg/day, for 6 weeks, with learning and memory assessed using the Passive Avoidance Test; cognitive function deficits were detected in aged mice, and these deficits were significantly mitigated by dietary treatments with EA-L3.

5.7 Digestive and Hepato-Biliary Uses (Traditional; No Modern Clinical Evidence)

The North American traditional uses for E. atropurpureus — as a liver tonic, cholagogue, cathartic, and diuretic — are extensively documented in 19th-century Eclectic medicine texts but have not been evaluated in modern controlled clinical studies. Historical records indicate it was used to stimulate the nutritive processes and improve the appetite, and might be used with advantage in atonic dyspepsia and in indigestion due to hepatic torpor or following malarial fevers. These accounts are historical-observational in nature and do not constitute clinical evidence.

6. Body Systems and Health Areas

Hepatobiliary system — historically described as a cholagogue and liver tonic; modern preclinical evidence for hepatoprotective effects against fibrosis and oxidative damage.
Gastrointestinal system — long-standing documented use as a cathartic, stomachic, and remedy for constipation and dyspepsia; historical use in dysentery.
Endocrine / Metabolic system — most active current research focus; preclinical antidiabetic, hypoglycemic, and hypolipidemic activities documented in cell and animal models.
Cardiovascular system — cardiac glycoside content imparts both historical therapeutic interest (digitalis-like action) and primary safety concern.
Renal / Urinary system — historical use as a diuretic; preclinical evidence for protection in diabetic nephropathy.
Musculoskeletal / Rheumatological system — traditional use in rheumatism across both Native American and Asian traditions; anti-inflammatory preclinical data.
Reproductive / Gynecological system — traditional use in Asian medicine for dysmenorrhea, irregular menstruation, and postpartum abdominal pain; in vitro aromatase inhibition studies.
Neurological system — emerging preclinical research on cognitive protection and anti-neuroinflammation in aged animal models.
Oncological (preclinical interest) — cytotoxic cardenolides and antiproliferative triterpenoids studied in cancer cell lines; no human data.

7. Dosage Forms and Reported Dosages

Dosage data in the literature is largely limited to historical Eclectic records (for E. atropurpureus) and animal/cell study concentrations (for E. alatus). No evidence-based human clinical dosing standard exists for either species.

7.1 Historical Eclectic Dosages (19th Century, E. atropurpureus)

Historical dosages recorded in King's American Dispensatory include: of the tincture, 1 to 4 fluid drachms; of the syrup, 1 to 2 fluid ounces; of the hydro-alcoholic extract, 5 to 15 grains; of the powder, 20 to 30 grains; of specific euonymus, 1 to 30 drops. Historical extract doses were very small, often about 60 to 200 mg per dose, but there is no evidence-based modern self-dosing standard.

7.2 Reported Concentrations in Preclinical Studies (E. alatus)

Aged mouse cognitive study (2024): E. alatus leaf extract (EA-L3) administered at 300 mg/kg/day for 6 weeks in 24-month-old mice.
Diabetic retinopathy study: KK-Ay mice were administered WEA (water extract of E. alatus) for 12 weeks.
PTP1B inhibition: Specific compounds exhibited potency with IC50 values ranging from 5.6 ± 0.9 to 18.4 ± 0.3 µM against PTP1B.
α-glucosidase inhibition: Compounds 15, 20, and 23 exhibited potent inhibition on α-glucosidase with IC50 values of 10.5 ± 0.8, 9.5 ± 0.6, and 9.1 ± 0.5 µM, respectively.

8. Safety Considerations and Interactions

8.1 Toxicity of the Whole Plant

The spindle tree (E. europaeus) and burning bush (E. atropurpureus) are reported as toxic to children and livestock, causing violent purgation, vomiting, and unconsciousness; poisoning in humans has most commonly been attributed to consumption of the fruit, but the bark and leaves are also toxic.

Although the bark, leaves, and fruits of eastern wahoo were formerly used for a variety of medicinal purposes, all parts of the plant are poisonous if ingested.

8.2 Cardiac Glycoside Toxicity

Cardiac glycosides present in Euonymus are naturally occurring compounds known to cause disruption in the natural rhythms of the heart and can also have a negative effect on the central nervous system; the concentration is low, but can have an effect if enough plant material is consumed; the highest concentration of these chemicals is stored in the fruits.

These compounds can influence heart function, especially if the dose is too high or if the user is vulnerable because of illness, dehydration, or medication interactions. Clinically, cardiac glycoside toxicity is characterized by predominant features including gastrointestinal signs, bradycardia, and heart block.

8.3 Dose-Dependent Gastrointestinal Effects

Wahoo is a strong laxative and, in larger doses, an emetic (causing vomiting). Both burning bush (E. atropurpureus) and the spindle tree are reported as causing violent purgation, vomiting, and unconsciousness. The purgative effect is dose-dependent and was purposefully exploited in traditional medicine at carefully controlled low doses.

8.4 Populations for Whom Use Is Specifically Contraindicated

The herb should be avoided by children, pregnant or breastfeeding people, and anyone with heart disease, electrolyte problems, or dehydration risk.

8.5 Drug Interactions

Given the digitalis-like cardiac glycoside content of E. atropurpureus, the potential for additive or synergistic toxicity with other cardiac glycoside drugs (e.g., digoxin), antiarrhythmic agents, and any medications affecting electrolyte balance (particularly potassium and calcium) is a primary concern documented in toxicological literature. The toxicological effects of this plant require further study; there are currently limited studies on its side effects and toxicological effects, which should provide further guidance for the safety of clinical use.

8.6 Invasive Species Concerns (E. alatus)

Euonymus alatus is prohibited in several states due to its tendency to spread aggressively and outcompete native vegetation; while the plant's adaptability and attractive foliage make it popular for landscaping, it requires careful management to prevent it from becoming a problematic weed.

8.7 Absence of Modern Clinical Safety Data

There is limited scientific evidence to conclusively support or characterize the use of burning bush in treating specific health conditions, and formal toxicological assessment in humans remains lacking. Most studies have been conducted without clinical research, and research into the plant's toxicological effects has also been limited.

9. Evidence Summary

The body of evidence for burning bush (Euonymus spp.) as a dietary supplement or medicinal plant is characterized by an extensive traditional record — particularly in 19th-century North American Eclectic medicine for E. atropurpureus and over two millennia of Asian use for E. alatus — and a growing but exclusively preclinical scientific literature. The review of Euonymus alatus bridges traditional uses with modern pharmacological insights, underscoring its potential in treating conditions such as cancer, diabetes, inflammation, and gynecological disorders. However, while E. alatus has potential for the treatment of many diseases, especially tumors and diabetes, many traditional uses have not been validated by current investigations, and modern studies have not gone far enough into its pharmacological effects and corresponding chemical constituents. No well-designed human clinical trials have been published for either species as of the current date.

References

Health Conditions

Health conditions that Burning bush may help support.

No conditions available.

Body Systems

Body systems that Burning bush may help support.

No body systems available.